Pacira BioSciences
PCRX
Pacira BioSciences (PCRX) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $36.50 from $38.00 | Oct 9, 2026 |
| RBC Capital | Maintained | Sector Perform | $36.50 from $25.00 | Oct 9, 2026 |
| Truist Securities | Downgraded | Buy → Hold | $36.50 from $31.00 | Oct 9, 2026 |
| Needham | Downgraded | Buy → Hold | — | Oct 8, 2026 |
| Jefferies | Downgraded | Buy → Hold | $36.00 | Oct 8, 2026 |
| JP Morgan | Upgraded | Underweight → Neutral | $36.50 | Oct 8, 2026 |
| Truist Securities | Maintained | Buy | $31.00 from $30.00 | Oct 7, 2026 |
| Oppenheimer | Initiated Coverage | Outperform | $32.00 | Sep 23, 2026 |
| Leerink Partners | Initiated Coverage | Market Perform | $28.00 | Sep 9, 2026 |
| Needham | Maintained | Buy | $33.00 from $32.00 | Aug 5, 2026 |
| RBC Capital | Maintained | Sector Perform | $25.00 from $24.00 | Aug 5, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 | Jul 1, 2026 |
| Needham | Maintained | Buy | $32.00 from $30.00 | May 1, 2026 |
| RBC Capital | Maintained | Sector Perform | $24.00 from $22.00 | May 1, 2026 |
| Barclays | Maintained | Equal-Weight | $25.00 from $27.00 | Mar 26, 2026 |
| Needham | Maintained | Buy | $30.00 | Jan 9, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $38.00 | Jan 9, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $27.00 | Dec 9, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $38.00 | Nov 17, 2025 |
| Truist Securities | Maintained | Buy | $28.00 from $30.00 | Nov 7, 2025 |
Frequently asked questions
What is the latest analyst rating on PCRX?
On Oct 9, 2026, HC Wainwright & Co. downgraded Pacira BioSciences to Neutral with a price target of $36.50.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.